Skip to main content

Advertisement

Log in

Can the Imbalance between Neurotrophic and Apoptotic Proteins Be the “Beware the Ides of March” for Unaffected Relatives of Schizophrenia Patients?

  • Published:
Molecular Neurobiology Aims and scope Submit manuscript

Abstract

Schizophrenia (SZ) is a mental disorder with a strong genetic basis as well as epigenetic aspects. Siblings of patients with SZ can share certain endophenotypes with the patients, suggesting that siblings may be important for distinguishing between trait and state markers. In the current study, we aimed to characterize the balance between pro-BDNF/mature BDNF and its receptors p75NTR/TrkB, which are tPA-BDNF pathways proteins and are thought to play a role in synaptic pruning, as a possible endophenotype of schizophrenia. Forty drug-naïve patients with first-episode psychosis (FEP) matched for age, gender, and level of education, 40 unaffected siblings (UAS) of patients with FEP, and 67 healthy controls (HC) were included in the study. Blood samples were collected from all participants to determine BDNF, pro-BDNF, TrkB and p75NTR, PAI1, tPA, ACTH, and cortisol levels. We showed that levels of proteins of the tPA-BDNF pathway as well as the pro-BDNF/m-BDNF and p75NTR/TrkB ratios could successfully differentiate FEP and their siblings from the HCs by using ROC analysis. Plasma levels of m-BDNF were found to be the lowest in the healthy siblings and highest in the HCs with statistically significant differences between all 3 groups. The plasma level of pro-BDNF in the HC group was similar to the FEP patients, the same in the healthy siblings of the FEP patients. Our data support the hypothesis that imbalance between neurotrophic and apoptotic proteins might occur in SZ and this imbalance could be an endophenotype of the disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Data Availability

Available upon request.

References

  1. Owen MJ, Sawa A, Mortensen PB (2016) Schizophrenia. Lancet 388(10039):86–97. https://doi.org/10.1016/S0140-6736(15)01121-6

    Article  PubMed  PubMed Central  Google Scholar 

  2. Lo LE, Kaur R, Meiser B, Green MJ (2020) Risk of schizophrenia in relatives of individuals affected by schizophrenia: a meta-analysis. Psychiatry Res 286:112852. https://doi.org/10.1016/j.psychres.2020.112852

    Article  Google Scholar 

  3. Sellgren CM et al (2019) Increased synapse elimination by microglia in schizophrenia patient-derived models of synaptic pruning. Nat Neurosci 22(3):374–385

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Blakemore S-J (2008) Development of the social brain during adolescence. Q J Exp Psychol 61(1):40–49

    Article  Google Scholar 

  5. Darabid H, Perez-Gonzalez AP, Robitaille R (2014) Neuromuscular synaptogenesis: coordinating partners with multiple functions. Nat Rev Neurosci 15(11):703–718

    Article  CAS  PubMed  Google Scholar 

  6. Neniskyte U, Gross CT (2017) Errant gardeners: glial-cell-dependent synaptic pruning and neurodevelopmental disorders. Nat Publ Gr 18(11):658–670. https://doi.org/10.1038/nrn.2017.110

    Article  CAS  Google Scholar 

  7. Cardozo PL, De Lima IBQ, Maciel EMA, Silva NC (2019) Synaptic elimination in neurological disorders. Curr Neuropharmacol 17:1071–1095. https://doi.org/10.2174/1570159X17666190603170511

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Presumey J, Bialas AR, Carroll MC (2017) Complement system in neural synapse elimination in development and disease, (1st ed. 135). Elsevier Inc

  9. Gogtay N et al (2004) Dynamic mapping of human cortical development during childhood through early adulthood. Proc Natl Acad Sci 101(21):8174–8179

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Riccomagno MM, Kolodkin AL (2015) Sculpting neural circuits by axon and dendrite pruning. Annu Rev Cell Dev Biol 31:779–805

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Moran ME, Pol HH, Gogtay N (2013) A family affair: brain abnormalities in siblings of patients with schizophrenia. Brain 136(11):3215–3226. https://doi.org/10.1093/brain/awt116

    Article  PubMed  PubMed Central  Google Scholar 

  12. Sun D et al (2009) Brain surface contraction mapped in first-episode schizophrenia: a longitudinal magnetic resonance imaging study. Mol Psychiatry 14(10):976–986. https://doi.org/10.1038/mp.2008.34

    Article  CAS  PubMed  Google Scholar 

  13. Je HS, Yang F, Ji Y, Nagappan G, Hempstead BL, Lu B (2012) Role of pro-brain-derived neurotrophic factor (proBDNF) to mature BDNF conversion in activity-dependent competition at developing neuromuscular synapses. Proc Natl Acad Sci U S A 109(39):15924–15929. https://doi.org/10.1073/pnas.1207767109

    Article  PubMed  PubMed Central  Google Scholar 

  14. Bibel M, Barde Y-A (2000) Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system. Genes Dev 14(23):2919–2937

    Article  CAS  PubMed  Google Scholar 

  15. Pezawas L et al (2004) The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. J Neurosci 24(45):10099–10102

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Toll A, Mané A (2015) Brain-derived neurotrophic factor levels in first episode of psychosis: a systematic review. World J Psychiatry 5(1):154

    Article  PubMed  PubMed Central  Google Scholar 

  17. Der Chen S, Wu CL, Hwang WC, Yang DI (2017) More insight into BDNF against neurodegeneration: anti-apoptosis, anti-oxidation, and suppression of autophagy. Int J Mol Sci 18(3):1–12. https://doi.org/10.3390/ijms18030545

    Article  CAS  Google Scholar 

  18. Yoshida T et al (2012) Decreased serum levels of mature brain-derived neurotrophic factor (BDNF), but not its precursor proBDNF, in patients with major depressive disorder. PLoS ONE 7(8):12–14. https://doi.org/10.1371/journal.pone.0042676

    Article  CAS  Google Scholar 

  19. Yesilkaya UH, Gica S, Tasdemir BG, Menekseoglu PO, Cirakli Z, Karamustafalioglu N (2021) A novel commentary: investigation of the role of a balance between neurotrophic and apoptotic proteins in the pathogenesis of psychosis via the tPA-BDNF pathway. J Psychiatr Res 142:160–166

    Article  PubMed  Google Scholar 

  20. Allen AJ, Griss ME, Folley BS, Hawkins KA, Pearlson GD (2009) Endophenotypes in schizophrenia: a selective review. Schizophr Res 109(1–3):24–37

    Article  PubMed  PubMed Central  Google Scholar 

  21. Yee JY, Lee TS, Lee J (2019) A longitudinal study of serum brain-derived neurotrophic factor levels in first-episode schizophrenia. J Clin Psychopharmacol 39(6):639–643. https://doi.org/10.1097/JCP.0000000000001118

    Article  CAS  PubMed  Google Scholar 

  22. Favalli G, Li J, Belmonte-de-Abreu P, Wong AHC, Daskalakis ZJ (2012) The role of BDNF in the pathophysiology and treatment of schizophrenia. J Psychiatr Res 46(1):1–11. https://doi.org/10.1016/j.jpsychires.2011.09.022

    Article  PubMed  Google Scholar 

  23. Chen S et al (2017) Combined serum levels of multiple proteins in tPA-BDNF pathway may aid the diagnosis of five mental disorders. Sci Rep 7(1):1–9. https://doi.org/10.1038/s41598-017-06832-6

    Article  CAS  Google Scholar 

  24. Foltran RB, Diaz SL (2016) BDNF isoforms: a round trip ticket between neurogenesis and serotonin? J Neurochem 138(2):204–221

    Article  CAS  PubMed  Google Scholar 

  25. Kumar V, Zhang M-X, Swank MW, Kunz J, Wu G-Y (2005) Regulation of dendritic morphogenesis by Ras–PI3K–Akt–mTOR and Ras–MAPK signaling pathways. J Neurosci 25(49):11288–11299

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Reichardt LF (2006) Neurotrophin-regulated signalling pathways. Philos Trans R Soc B Biol Sci 361(1473):1545–1564

    Article  CAS  Google Scholar 

  27. Anastasia A et al (2013) Val66Met polymorphism of BDNF alters prodomain structure to induce neuronal growth cone retraction. Nat Commun 4(1):1–13

    Article  Google Scholar 

  28. Gehler S, Gallo G, Veien E, Letourneau PC (2004) p75 neurotrophin receptor signaling regulates growth cone filopodial dynamics through modulating RhoA activity. J Neurosci 24(18):4363–4372

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Bamji SX et al (1998) The p75 neurotrophin receptor mediates neuronal apoptosis and is essential for naturally occurring sympathetic neuron death. J Cell Biol 140(4):911–923

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Kowiański P, Lietzau G, Czuba E, Waśkow M, Steliga A, Moryś J (2018) BDNF: a key factor with multipotent impact on brain signaling and synaptic plasticity. Cell Mol Neurobiol 38(3):579–593. https://doi.org/10.1007/s10571-017-0510-4

    Article  CAS  PubMed  Google Scholar 

  31. Yang J et al (2014) proBDNF negatively regulates neuronal remodeling, synaptic transmission, and synaptic plasticity in hippocampus. Cell Rep 7(3):796–806

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Karanikas E, Antoniadis D, Garyfallos GD (2014) The role of cortisol in first episode of psychosis: a systematic review. Curr Psychiatry Rep 16(11):1–10. https://doi.org/10.1007/s11920-014-0503-7

    Article  Google Scholar 

  33. Howes OD, McCutcheon R (2017) Inflammation and the neural diathesis-stress hypothesis of schizophrenia: a reconceptualization. Transl Psychiatry 7(2):e1024–e1024

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Hubbard DB, Miller BJ (2019) Meta-analysis of blood cortisol levels in individuals with first-episode psychosis. Psychoneuroendocrinology 104:269–275

    Article  CAS  PubMed  Google Scholar 

  35. Walsh P, Spelman L, Sharifi N, Thakore JH (2005) Male patients with paranoid schizophrenia have greater ACTH and cortisol secretion in response to metoclopramide-induced AVP release. Psychoneuroendocrinology 30(5):431–437

    Article  CAS  PubMed  Google Scholar 

  36. Hoirisch-Clapauch S, Nardi AE (2015) Improvement of psychotic symptoms and the role of tissue plasminogen activator. Int J Mol Sci 16(11):27550–27560. https://doi.org/10.3390/ijms161126053

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Almonte AG, Sweatt JD (2011) Serine proteases, serine protease inhibitors, and protease-activated receptors: roles in synaptic function and behavior. Brain Res 1407:107–122

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Elmi S, Sahu G, Malavade K, Jacob T (2019) Role of tissue plasminogen activator and plasminogen activator inhibitor as potential biomarkers in psychosis. Asian J Psychiatr 43(May):105–110. https://doi.org/10.1016/j.ajp.2019.05.021

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We are grateful to the University of (University of Health Sciences Turkey) Research Projects Unit, Turkey, because of their financial support for the current research.. In addition, our work has been awarded by the ECNP community at the 2020 ECNP congress.

Funding

Financial support for the current research was provided by the University of (University of Health Sciences Turkey) Research Projects Unit (Date/ Number; 07.03.2019/020).

Author information

Authors and Affiliations

Authors

Contributions

UHY and SG wrote the manuscript and. BGT and POM collected all the data. ZC analyzed the serum levels of the proteins. NK was responsible for overseeing and coordination of the research. All authors provided feedback and final approval on the manuscript.

Corresponding author

Correspondence to Umit Haluk Yesilkaya.

Ethics declarations

Consent to Participate

All participants provided their written informed consent.

Consent for Publication

N/A

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yesilkaya, U.H., Gica, S., Menekseoglu, P.O. et al. Can the Imbalance between Neurotrophic and Apoptotic Proteins Be the “Beware the Ides of March” for Unaffected Relatives of Schizophrenia Patients?. Mol Neurobiol 59, 7413–7422 (2022). https://doi.org/10.1007/s12035-022-03054-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12035-022-03054-4

Keywords

Navigation